#nonsmallcell

Significant variation found in timing and selection of genetic tests for non-small-cell lung cancer

The tests are ordered chronologically. Each row represents the biomarker test combination for one patient. Numbers shown on the right indicate the number of patients who received the same biomarker test combination. Credit: van de Ven, Michiel, et al. Biomarker testing surveys specific disease-associated molecules to predict treatment response and disease progression; however its use has…